Mark Guerin - Mar 13, 2024 Form 4 Insider Report for Onconova Therapeutics, Inc. (ONTX)

Role
CFO AND COO
Signature
/s/ Mark Guerin
Stock symbol
ONTX
Transactions as of
Mar 13, 2024
Transactions value $
-$2,332
Form type
4
Date filed
3/15/2024, 05:40 PM
Previous filing
Feb 9, 2024
Next filing
Jun 20, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ONTX Common Stock Options Exercise +8.67K +28.98% 38.6K Mar 13, 2024 Direct F1
transaction ONTX Common Stock Tax liability -$2.33K -2.59K -6.72% $0.90 36K Mar 14, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ONTX Restricted Stock Units Options Exercise $0 -8.67K -33.33% $0.00 17.3K Mar 13, 2024 Common Stock 8.67K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units convert into common stock on a one-for-one basis.
F2 On March 13, 2023 the reporting person was granted 26,000 restricted stock units which vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34% on the third anniversary.